Condition: Acute Kidney Injury (Nontraumatic) · Sponsor: University Hospital Muenster
There is no specific therapy for acute kidney injury. It is presumed that supportive measures improve the care and outcome of patients with acute kidney injury. To investigate whether an implementation of a supportive extended care "bundle" in high-risk patients for persistent acute kidney injury (AKI) can reduce the occurrence of persistent surgical AKI. In order to investigate whether the extended KDIGO bundle can prevent persistent AKI in patients with high chemokine ligand 14 (CCL14) as well as in patients with low CCL14, patients will be randomized with stratification by the CCL-value.
This description comes directly from the study's public registry record.
Zarbock, MD · +49-251-8347252 · aki@anit.uni-muenster.de
Meersch, MD · aki@anit.uni-muenster.de
Always discuss trial participation with your own doctor first.
| University Hospital Münster; 1Department of Anesthesiology, Intensive Care Medicine and Pain Medicine | Münster, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05275218